CD79A and asthma: Mucosal IgA is another key component in protection against RSV: during RSV infection, IgA secretion from B-cells is activated through IFN-α, which is decreased in preterm infants, suggesting that IgA responses may be diminished, increasing susceptibility to develop severe disease, which is associated with long-term complications such as wheezing and asthma [15].